Cargando…
Low Serum Lysosomal Acid Lipase Activity Correlates with Advanced Liver Disease
Fatty liver has become the most common liver disorder and is recognized as a major health burden in the Western world. The causes for disease progression are not fully elucidated but lysosomal impairment is suggested. Here we evaluate a possible role for lysosomal acid lipase (LAL) activity in liver...
Autores principales: | Shteyer, Eyal, Villenchik, Rivka, Mahamid, Mahmud, Nator, Nidaa, Safadi, Rifaat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4813175/ https://www.ncbi.nlm.nih.gov/pubmed/26927097 http://dx.doi.org/10.3390/ijms17030312 |
Ejemplares similares
-
Hepatotoxicity of tocilizumab and anakinra in rheumatoid arthritis: management decisions
por: Mahamid, Mahmud, et al.
Publicado: (2011) -
Hepatotoxicity due to tocilizumab and anakinra in rheumatoid arthritis: two case reports
por: Mahamid, Mahmud, et al.
Publicado: (2011) -
Portal lymphadenopathy predicts non-alcoholic steatohepatitis and advanced fibrosis in non-alcoholic fatty liver disease
por: Daher, Saleh, et al.
Publicado: (2018) -
Insulin signaling as a potential natural killer cell checkpoint in fatty liver disease
por: Amer, Johnny, et al.
Publicado: (2018) -
Lysosomal acid lipase in cancer
por: Yan, Cong, et al.
Publicado: (2015)